mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.09 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.09 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |